| 000 | 01720 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513175804.0 | ||
| 264 | 0 | _c19990603 | |
| 008 | 199906s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm980657j _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNandanan, E | |
| 245 | 0 | 0 |
_aStructure-activity relationships of bisphosphate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cMay 1999 |
||
| 300 |
_a1625-38 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aDeoxyadenosines _xchemical synthesis |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 |
_aErythrocyte Membrane _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aOrganophosphates _xchemical synthesis |
| 650 | 0 | 4 | _aPurinergic P2 Receptor Agonists |
| 650 | 0 | 4 | _aPurinergic P2 Receptor Antagonists |
| 650 | 0 | 4 |
_aReceptors, Purinergic P2 _xbiosynthesis |
| 650 | 0 | 4 | _aReceptors, Purinergic P2Y1 |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 | _aTurkeys |
| 650 | 0 | 4 |
_aType C Phospholipases _xmetabolism |
| 700 | 1 | _aCamaioni, E | |
| 700 | 1 | _aJang, S Y | |
| 700 | 1 | _aKim, Y C | |
| 700 | 1 | _aCristalli, G | |
| 700 | 1 | _aHerdewijn, P | |
| 700 | 1 | _aSecrist, J A | |
| 700 | 1 | _aTiwari, K N | |
| 700 | 1 | _aMohanram, A | |
| 700 | 1 | _aHarden, T K | |
| 700 | 1 | _aBoyer, J L | |
| 700 | 1 | _aJacobson, K A | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 42 _gno. 9 _gp. 1625-38 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm980657j _zAvailable from publisher's website |
| 999 |
_c10188657 _d10188657 |
||